These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5631364)

  • 1. Formycin-deaminating activity of microorganisms.
    Sawa T; Fukagawa Y; Homma I; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1967 Nov; 20(6):317-21. PubMed ID: 5631364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative characteristics of toxic substances produced by some bacteria, fungi and Actinomycetes].
    Egorova SA; Kuimova TF
    Antibiotiki; 1973 Sep; 18(9):854-8. PubMed ID: 4761960
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on formycin and formycin B in cells of Ehrlich carcinoma and E. coli.
    Umezawa H; Sawa T; Fukagawa Y; Homma I; Ishizuka M
    J Antibiot (Tokyo); 1967 Nov; 20(6):308-16. PubMed ID: 4872074
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of formycin and formycin B in vitro.
    Ishizuka M; Sawa T; Koyama G; Takahashi T; Umezawa H
    J Antibiot (Tokyo); 1968 Jan; 21(1):1-4. PubMed ID: 5673289
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioconversions of saframycin A specific to some genera of actinomycetes.
    Yazawa K; Asaoka T; Takahashi K; Mikami Y; Arai T
    J Antibiot (Tokyo); 1982 Jul; 35(7):915-7. PubMed ID: 7174541
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibitors of tumor growth; metabolic products of actinomycetes].
    Illarionova RP; Bondarenko BN; Dikhovichna DE; Skripka LI
    Mikrobiol Zh; 1971; 33(6):773-5. PubMed ID: 5153569
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extraction method for production of the antibiotic sibiromycin].
    Pokras LS; Krugliak EB; Tolstykh IV; Brazhnikova MG
    Antibiotiki; 1972 Aug; 17(8):697-701. PubMed ID: 4635250
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new variety of Actinoplanes-producing sibiromycin].
    Hu JL; Xie MY; Lu WY
    Wei Sheng Wu Xue Bao; 1986 Mar; 26(1):90-3. PubMed ID: 3604209
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening of catalytically active microorganisms for the synthesis of 6-modified purine nucleosides.
    Trelles JA; Valino AL; Runza V; Lewkowicz ES; Iribarren AM
    Biotechnol Lett; 2005 Jun; 27(11):759-63. PubMed ID: 16086256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of the antiblastogram in the selection of new lines of microorganisms producing antineoplastic antibiotics].
    Briones-Carrillo D; Alvarez-Rodríguez Y; Valladares Y
    Rev Esp Oncol; 1983; 30(4):595-601. PubMed ID: 6400623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation.
    Berman JD
    J Parasitol; 1984 Aug; 70(4):561-2. PubMed ID: 6502359
    [No Abstract]   [Full Text] [Related]  

  • 13. [The problem of hydrocarbon microbiology].
    Ierusalimskiĭ ND; Skriabin GK
    Izv Akad Nauk SSSR Biol; 1965; 1():53-7. PubMed ID: 5859918
    [No Abstract]   [Full Text] [Related]  

  • 14. The studies on the chemical derivations of formycin and formycin B.
    Watanabe S; Matsuhashi G; Fukatsu S; Koyama G; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1966 Mar; 19(2):93-6. PubMed ID: 5952900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphological properties of the producer of the antineoplastic antibiotic sibiromycin: Streptosporangium sibiricum Gause et al., 1969, in submerged cultures].
    Ivanitskaia LP
    Antibiotiki; 1971 Mar; 16(3):233-6. PubMed ID: 5558684
    [No Abstract]   [Full Text] [Related]  

  • 16. [Microbial succession on lignite along with weathering].
    Yuan H; Chen W; Kimura M
    Wei Sheng Wu Xue Bao; 1998 Dec; 38(6):411-6. PubMed ID: 12548918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutasynthesis of a potent anticancer sibiromycin analogue.
    Yonemoto IT; Li W; Khullar A; Reixach N; Gerratana B
    ACS Chem Biol; 2012 Jun; 7(6):973-7. PubMed ID: 22390171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic and antitumor antibiotics produced by microorganisms.
    Oki T
    Biotechnol Bioeng; 1980; 22 Suppl 1():83-97. PubMed ID: 6159010
    [No Abstract]   [Full Text] [Related]  

  • 19. Uptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells.
    Borgland SL; Parkinson FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):347-53. PubMed ID: 9103516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for non-polyenic antifungal antibiotics produced by rare Actinomycetales.
    Hacène H; Sabaou N; Bounaga N; Lefebvre G
    Microbios; 1994; 79(319):81-5. PubMed ID: 7968663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.